OpenQ has been helping our European customers manage compliant business processes since 2005
Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) May 4, 2010
OpenQ is pleased to announce the signing of its latest European customer. This customer, the tenth major pharmaceutical or medical device company openQ is serving in Europe, purchased a solution to help ensure the compliance and effectiveness of their Key Opinion Leader (KOL) programs.
Risks such as multi-million dollar fines are becoming more common in the life sciences industry. Regulations are changing quickly and to keep up companies are forced to spend an increasing amount of their resources focused on compliance, rather than on their business mission of patient health. By easing the ever-increasing burden of compliance, openQ’s software and research offerings translate into customers spending less time managing compliance and more time focusing on business.
“Compliance is a global challenge for life sciences companies,” said Jim Zuffoletti, President and co-Founder of openQ. “OpenQ has been helping our European customers manage compliant business processes since 2005 and are very excited to serve our latest customer. We are pleased to have a broad portfolio which can address the urgent needs of the world’s leading pharmaceutical and medical device companies.”
The easy implementation and high configurability of OpenQ’s solutions are very important when answering the pressing need for compliance in Life Sciences. Further, a robust support organization, with flexible customer options, allows OpenQ to efficiently and effectively provide the right solution for each of their customers.
Based in Charlottesville, Virginia, OpenQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. OpenQ offers award winning solutions for compliant business processes focused on KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs . OpenQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit openq.com.